Save time and jump to the most important pieces.
| Company | Date | Price Target | Rating | Analyst |
|---|---|---|---|---|
| 8/8/2024 | $30.00 → $31.00 | Buy → Hold | Truist | |
| 7/19/2024 | $3.00 → $4.00 | Neutral | Citigroup | |
| 4/2/2024 | $5.00 → $1.50 | Buy → Underperform | BofA Securities | |
| 12/19/2023 | $22.00 | Buy | Jefferies | |
| 12/19/2023 | $3.11 | Hold | Jefferies | |
| 11/30/2023 | $8.00 → $3.00 | Outperform → Neutral | Robert W. Baird | |
| 11/29/2023 | Overweight → Equal Weight | Wells Fargo | ||
| 9/29/2023 | Peer Perform | Wolfe Research |
Citigroup analyst Steven Zaccone maintains Petco Health and Wellness (NASDAQ:WOOF) with a Neutral and raises the price target from $3 to $4.
Providing a diverse range of perspectives from bullish to bearish, 7 analysts have published ratings on Petco Health and Wellness (NASDAQ:WOOF) in the last three months. The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 1 4 2 0 0 Last 30D 0 1 0 0 0 1M Ago 0 0 0 0 0 2M Ago 1 3 1 0 0 3M Ago 0 0 1 0 0 Analysts have recently evaluated Petco Health and Wellness and provided 12-month price targets. The average target is $3.71, accompanied by a high estimate of $5.00 and a low estimate of $
Wedbush analyst Seth Basham maintains Petco Health and Wellness (NASDAQ:WOOF) with a Outperform and raises the price target from $4 to $5.
Ordergroove's technology streamlines the subscription and membership experience, with ready-to-use functionalities like prepaid subscriptions, self-service management, and personalized promotions. Ordergroove, the leading technology platform that powers subscriptions for top brands and retailers, today announced a strategic partnership with PetMed Express, Inc. (NASDAQ:PETS), the original online pet pharmacy dedicated to supporting the health and well-being of four-legged family members. This collaboration marks a significant step in modernizing and scaling PetMeds + PetCareRx's (PETS) subscription and membership capabilities to maximize operational efficiency and deliver innovative and e
SAN DIEGO, Nov. 13, 2024 /PRNewswire/ -- Petco Health and Wellness Company, Inc. (NASDAQ:WOOF) today announced Joe Venezia will join the company as Chief Revenue Officer, effective Nov. 17, reporting to Joel Anderson, Chief Executive Officer. In this newly created role, Venezia will be responsible for driving revenue and developing integrated strategies to improve the customer experience. Joe will oversee critical areas that contribute to Petco's growth, including pet care centers, pet and veterinary services, real estate and customer success capabilities. "Joe is a proven sal
DELRAY BEACH, Fla., Nov. 07, 2024 (GLOBE NEWSWIRE) -- PetMed Express, Inc., dba PetMeds and parent company of PetCareRx, (NASDAQ:PETS), will participate in the Sidoti Micro Cap Conference, to be held November 13-14, 2024 virtually. Sandra Campos, CEO and President, will meet with investors and present at approximately 1:45 p.m. Eastern Time on Wednesday, November 13, 2024. A live webcast of the presentation will be available on the "Events & Presentations" section of PetMed's investor relations website at https://investors.petmeds.com or directly here. About PetMed Express, Inc. Founded in 1996, PetMeds is a leader in the consumer pet healthcare sector. As a national online retailer wit
SC 13G/A - PetIQ, Inc. (0001668673) (Subject)
SC 13G - PETMED EXPRESS INC (0001040130) (Subject)
SC 13G/A - PetIQ, Inc. (0001668673) (Subject)
4 - Petco Health & Wellness Company, Inc. (0001826470) (Issuer)
3 - Petco Health & Wellness Company, Inc. (0001826470) (Issuer)
4 - Petco Health & Wellness Company, Inc. (0001826470) (Issuer)
10-Q - PETMED EXPRESS INC (0001040130) (Filer)
8-K - PETMED EXPRESS INC (0001040130) (Filer)
15-12G - PetIQ, Inc. (0001668673) (Filer)
Truist downgraded PetIQ from Buy to Hold and set a new price target of $31.00 from $30.00 previously
Citigroup reiterated coverage of Petco Health and Wellness with a rating of Neutral and set a new price target of $4.00 from $3.00 previously
BofA Securities downgraded Petco Health and Wellness from Buy to Underperform and set a new price target of $1.50 from $5.00 previously
SAN DIEGO, Nov. 13, 2024 /PRNewswire/ -- Petco Health and Wellness Company, Inc. (NASDAQ:WOOF) today announced Joe Venezia will join the company as Chief Revenue Officer, effective Nov. 17, reporting to Joel Anderson, Chief Executive Officer. In this newly created role, Venezia will be responsible for driving revenue and developing integrated strategies to improve the customer experience. Joe will oversee critical areas that contribute to Petco's growth, including pet care centers, pet and veterinary services, real estate and customer success capabilities. "Joe is a proven sal
DELRAY BEACH, Fla., Sept. 12, 2024 (GLOBE NEWSWIRE) -- PetMed Express, Inc., dba PetMeds and parent company of PetCareRx, (NASDAQ:PETS) (the "Company") today announced the appointment of retail and ecommerce veteran Robyn D'Elia as Chief Financial Officer ("CFO") effective September 16, 2024. D'Elia brings over 25 years of experience in financial leadership and strategic planning across multiple industries, including 24 years at Bed Bath & Beyond where she served in senior leadership roles across finance for two decades, and served as CFO from 2018 to 2020. Most recently D'Elia served as CFO at Odeko, a privately held all-in-one operations partner for independent coffee shops, cafes and ot
DELRAY BEACH, Fla., Aug. 05, 2024 (GLOBE NEWSWIRE) -- PetMed Express, Inc., dba PetMeds and parent company of PetCareRx, (NASDAQ:PETS) (the "Company") today announced the appointment of Doug Krulik as Chief Accounting Officer (CAO) effective August 19, 2024. Krulik comes to PetMeds with more than 20 years of leadership experience in finance and accounting, most recently with Etherio Holdings as its Vice President Finance and Controller. In this newly created role, he will oversee all aspects of the Company's accounting functions, including financial reporting, treasury, tax, compliance, and internal controls. Krulik will report directly to the Office of the Chief Financial Officer. "Doug'
DELRAY BEACH, Fla., Nov. 06, 2024 (GLOBE NEWSWIRE) -- PetMed Express, Inc. dba PetMeds and parent company of PetCareRx (NASDAQ:PETS) today announced its financial results for its second quarter ended September 30, 2024. Second Quarter Fiscal 2025 Financial Highlights Net sales of $59.6 million.Gross margin of 29.1%, an increase of 0.8% compared to the prior year period.Net income of $2.3 million, or $0.11 per diluted share, compared to net income of $0.7 million, or $0.03 per diluted share, in the prior year period. Adjusted EBITDA of $2.1 million improved sequentially from an Adjusted EBITDA loss of $(1.5) million in the first quarter of fiscal 2025 and compared to Adjusted EBITDA of $
DELRAY BEACH, Fla., Oct. 24, 2024 (GLOBE NEWSWIRE) -- PetMed Express, Inc., dba PetMeds and parent company of PetCareRx, (NASDAQ:PETS) will hold a conference call on Wednesday, November 6, 2024 at 4:30pm Eastern Time to discuss its financial results for the fiscal second quarter ended September 30, 2024. Financial results will be issued in a press release prior to the call. PETS management will host the conference call, followed by a question-and-answer period. Please call the conference telephone number 5-10 minutes prior to the start time. Date: Wednesday, November 6, 2024Time: 4:30pm Eastern Time (1:30pm Pacific Time)U.S. dial-in number: 877-407-0789International number: 201-689-8
Q2 2024 Overview Net revenue of $1.52 billion decreased 0.5 percent year over year Comparable sales increased 0.3 percent year over year and increased 3.5 percent on a two-year basis GAAP net loss of $24.8 million, or $(0.09) per share, compared to GAAP net loss of $14.6 million, or $(0.05) per share in the prior yearAdjusted EBITDA1 of $83.5 million compared to $112.6 million in the prior yearOperating Cash Flow of $69.4 million compared to $96.6 million in the prior yearFree Cash Flow 1 of $42.0 million compared to $44.6 million in the prior yearSAN DIEGO, Sept. 10, 2024 /PRNewswire/ -- Petco Health and Wellness Company, Inc. (NASDAQ:WOOF), a complete partner in pet health and wellness, to
4 - PETMED EXPRESS INC (0001040130) (Issuer)
4 - Petco Health & Wellness Company, Inc. (0001826470) (Issuer)
4 - Petco Health & Wellness Company, Inc. (0001826470) (Issuer)